In Vitro Diagnostics: Technologies and Global Markets

Report Code: HLC186A

Publish Date: Nov 2015

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

Report Includes

  • An overview of the global markets and related technologies for in vitro diagnostics
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD
  • Information about IVD products including reagents, instruments, and data management softwares and services
  • A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories
  • Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics
  • Geographical breakdowns
  • Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others.
  • Profiles of major players in the industry

SCOPE OF REPORT

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

  • Structure and current market size of the IVD market as outlined with forecasts through 2020.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the IVD industry and trends affecting the market.
  • Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions.
  • Emerging opportunities and potential investment opportunity areas for IVD.
  • Technology patent trends relating to IVD.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

ANALYST’S CREDENTIALS

Sangeetha Prabakar is an experienced market research analyst with over 13 years of professional experience in research/consulting/competitive intelligence in the life sciences sector with varied coverage in pharmaceuticals, biotechnology, medical devices and imaging, patient monitoring, clinical diagnostics and drug discovery sectors. Ms. Sangeetha has specialized in biochemistry and human genetics in her academic studies. Though her vast experience and in-depth knowledge gained over the years, she provides strategic analysis and recommendations in her market studies, enabling the readers to make informed decisions.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: In Vitro Diagnostics: Technologies and Global Markets192Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: MARKET LANDSCAPE16Free
Chapter- 4: GLOBAL IVD MARKET BY SUBCATEGORIES6Free
Chapter- 5: GLOBAL IMMUNOCHEMISTRY MARKET8Free
Chapter- 6: GLOBAL POC TESTING MARKET8Free
Chapter- 7: GLOBAL HEMATOLOGY MARKET7Free
Chapter- 8: GLOBAL MOLECULAR DIAGNOSTICS MARKET13Free
Chapter- 9: GLOBAL CLINICAL MICROBIOLOGY MARKET5Free
Chapter- 10: GLOBAL TISSUE DIAGNOSTICS MARKET6Free
Chapter- 11: GLOBAL IVD MARKET BY END USERS2Free
Chapter- 12: GLOBAL IVD MARKET PRODUCTS3Free
Chapter- 13: REGIONAL ANALYSIS40Free
Chapter- 14: EMERGING GLOBAL TECHNOLOGY TRENDS AND DEVELOPMENTS17Free
Chapter- 15: TECHNOLOGY DEVELOPMENT OPPORTUNITIES IN IVD INDUSTRY11Free
Chapter- 16: FUNDING ANALYSIS AND INDUSTRY ACTIVITY14Free
Chapter- 17: PATENT LANDSCAPE11Free
Chapter- 18: C. CRAMER & CO. GMBH15Free
Chapter- 19: APPENDIX3Free

Related Reports

Next Generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Jun 2015 | Publisher - John Bergin | Code - BIO126B

The global clinical next-generation sequencing (NGS) market was valued at $886.1 million in 2014. This market is expected to grow at a compound annual growth rate (CAGR) of 31.3%, from $997.1 million in 2015 to nearly $3.9 billion by 2020.

The Global Blood Industry

Published - Mar 2015 | Publisher - Melissa Elder | Code - HLC008J

Global sales of blood products grew to nearly $30.2 billion in 2014 from $28.7 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2014 to 2019, totaling nearly $38.3 billion in 2019.

Antibody Drugs: Technologies and Global Markets

Published - Jan 2015 | Publisher - Shalini Shahani Dewan | Code - BIO016J

The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019.

Global Markets and Technologies for Food Safety Testing

Published - Oct 2014 | Publisher - Kevin Gainer | Code - FOD011H

The global food safety testing market reached $10.5 billion in 2014, and should reach about $13.6 billion in 2019 with a five year compound annual growth (CAGR) of 5.3% through 2019.

Recent Reports

Prefilled Syringes: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC223B

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
In Vitro Diagnostics: Technologies and Global Markets
Customize Report